There is a newer version of the record available.

Published November 27, 2020 | Version 0

Elongation of very long chain fatty acids protein 7 (ELOVL7); A Target Enabling Package

  • 1. Centre for Medicines Discovery, Old Road Campus Research Building, Headington, Oxford OX3 7DQ, UK
  • 2. Albert Einstein College of Medicine, Department of Biochemistry, New York, NY 10461-1602, USA

Description

The long-chain fatty acid elongases (ELOVL) catalyse the first rate-limiting step in the two carbon elongation of the acyl chains of fatty acids (FAs) greater than 12 carbons in length. Defects in these ELOVL elongases cause severe genetic diseases, such as Stargardt disease-3 and several ataxias, and knockout studies suggest roles in insulin resistance and hepatic steatosis. This TEP provides the first structural information for this family of enzymes which, coupled with mutagenesis and biophysical studies, demonstrates how substrates and products bind within the active site.

Notes

Future versions of this TEP will contain experimental data on the ELOVL7 TEP.

Files

ELOVL7_TEP_v0.pdf

Files (485.1 kB)

Name Size Download all
md5:93511d2f93b06193b77e004821abbec7
485.1 kB Preview Download

Additional details

Related works

Funding

Wellcome Trust
A UK Hub to Catalyse Open Target Discovery. 106169